{"schema_version":"secwatch.filing_event.v1","accession":"0001023024-25-000056","form_type":"8-K","ticker":"ANIP","cik":"0001023024","company_name":"ANI PHARMACEUTICALS INC","filed_at":"2025-05-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.171007+00:00","generated_at":"2026-05-20T12:50:16.111731+00:00","sec_items":["5.02","5.03","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"ANI shareholders approve doubling authorized common shares to 66M and equity plan amendments","bullets":["Stockholders approved Certificate of Amendment raising authorized common shares from 33,333,334 to 66,000,000; effective May 22, 2025.","Amended 2022 Stock Incentive Plan approved (15,056,885 for, 1,202,893 against, 10,460 abstain).","Amended 2016 Employee Stock Purchase Plan approved (16,173,976 for, 89,098 against, 7,164 abstain).","Eight director nominees elected; EisnerAmper LLP ratified as auditor; say-on-pay advisory approved."],"urls":{"canonical":"https://secwatch.observer/filing/0001023024-25-000056","json":"https://secwatch.observer/filing/0001023024-25-000056.json","markdown":"https://secwatch.observer/filing/0001023024-25-000056.md","text":"https://secwatch.observer/filing/0001023024-25-000056.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1023024/000102302425000056/0001023024-25-000056-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1023024/000102302425000056/ani-20250522.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T12:50:16.111731+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e7cb1761176c092247e95096e4aacfda0091b8c7","claim":"ANI PHARMACEUTICALS INC: Amended Restated Certificate of Incorporation to increase authorized common stock from 33,333,334 to 66,000,000 shares (effective 2025-05-22).","evidence_excerpt":"the amendment to the Company’s Restated Certificate of Incorporation (the “Certificate of Amendment”), providing for an increase to the number of authorized shares of common stock from 33,333,334 shares to 66,000,000 shares","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1023024/000102302425000056/0001023024-25-000056-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2025-05-22"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}